IRIS Registry: Intelligent Research in Sight Registry

Description

The IRIS™ Registry (Intelligent Research in Sight) is the nation's first comprehensive eye disease clinical registry. The American Academy of Ophthalmology is developing it as part of the profession's shared goal of continual improvement in the delivery of eye care.The IRIS Registry will be a centralized system for ophthalmology practices to promote practice innovations and achieve clinical excellence.

Conditions

Eye Diseases

Study Overview

Study Details

Study overview

The IRIS™ Registry (Intelligent Research in Sight) is the nation's first comprehensive eye disease clinical registry. The American Academy of Ophthalmology is developing it as part of the profession's shared goal of continual improvement in the delivery of eye care.The IRIS Registry will be a centralized system for ophthalmology practices to promote practice innovations and achieve clinical excellence.

IRIS Registry: Intelligent Research in Sight Registry

IRIS Registry: Intelligent Research in Sight Registry

Condition
Eye Diseases
Intervention / Treatment

-

Contacts and Locations

San Francisco

American Academy of Opthalmology, San Francisco, California, United States, 94109

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients who meet the denominator requirements for each measure.
  • * None

Ages Eligible for Study

6 Months to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

American Academy of Ophthalmology,

Flora Lum, MD, STUDY_DIRECTOR, American Academy of Ophthalmology

Study Record Dates

2100-01